Nashville, TN, United States of America

Mine Ikizler

This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mine Ikizler. Retrieved from https://idiyas.com/inventor/mine-ikizler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mine Ikizler: Innovator in Reovirus Vaccines

Introduction

Mine Ikizler is a prominent inventor based in Nashville, TN (US). She has made significant contributions to the field of immunology through her innovative work on reovirus vaccines. Her research focuses on developing modified reoviruses that can elicit immune responses against various pathogens.

Latest Patents

Mine Ikizler holds 1 patent for her invention titled "Reovirus vaccines and methods of use therefor." This patent provides for modified reoviruses that carry α-helical epitopes from a variety of pathogens. The methods outlined in her patent aim to generate immune responses against these epitopes in hosts, showcasing her commitment to advancing vaccine technology.

Career Highlights

Mine Ikizler is affiliated with Vanderbilt University, where she conducts her research. Her work has positioned her as a key figure in the development of innovative vaccine strategies. She continues to explore new avenues in immunology, contributing to the scientific community's understanding of viral vaccines.

Collaborations

Mine has collaborated with notable colleagues, including Karl W Boehme and Gregory J Wilson. These partnerships enhance her research efforts and foster a collaborative environment for innovation in vaccine development.

Conclusion

Mine Ikizler's contributions to the field of reovirus vaccines exemplify her dedication to advancing medical science. Her innovative approaches and collaborations continue to pave the way for future breakthroughs in immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…